Drug intelligence / Profile preview

Cure-Allergic Rhinitis Syrup

Development stage: Phase 2
Lead developer: The Hong Kong Polytechnic University
Administration: Oral

Overview

Cure-Allergic Rhinitis Syrup is a Chinese herbal medicine formulation developed for the treatment of allergic rhinitis (AR). It was specifically evaluated in a randomized controlled trial conducted by The Hong Kong Polytechnic University, targeting nursing students with AR and a Cold/Yang-Deficiency body constitution. The syrup is designed to alleviate AR symptoms, improve body constitution patterns, and enhance health-related quality of life. In clinical studies, its efficacy has been compared to the traditional formula Yu-ping-fung San and a placebo.

Other names: Cure-Allergic

Beyond the preview

Go deeper on Cure-Allergic Rhinitis Syrup.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cure-Allergic Rhinitis Syrup.

Explore the full profile